These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 3104218)

  • 1. Pharmacokinetics and pharmacological properties of two galenical preparations of glibenclamide, HB419 and HB420, in non insulin-dependent (type 2) diabetes.
    Scheen AJ; Jaminet C; Luyckx AS; Lefebvre PJ
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):70-6. PubMed ID: 3104218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo action of glibenclamide in obese subjects with mild type 2 (non-insulin dependent) diabetes.
    Hother-Nielsen O; Schmitz O; Andersen PH; Pedersen O; Beck-Nielsen H
    Diabetes Res; 1988 Jun; 8(2):63-70. PubMed ID: 3147830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of insulin and glibenclamide in the treatment of elderly non-insulin dependent (type 2) diabetic patients.
    Kyllästinen M; Groop L
    Ann Clin Res; 1985; 17(3):100-4. PubMed ID: 3931537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C; Haupt E; Walter T; Werner J
    Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacodynamics and pharmacokinetics of 2 glibenclamide preparations in type 2 diabetes. Intraindividual double-blind comparison of Euglucon 5 (HB 419) and Euglucon N (HB 420)].
    Haupt E; Putschky F; Zoltobrocki M; Schöffling K
    Dtsch Med Wochenschr; 1984 Feb; 109(6):210-3. PubMed ID: 6421561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and effects of glibenclamide in two formulations, HB 419 and HB 420, in type 2 diabetes.
    Arnqvist HJ; Karlberg BE; Melander A
    Ann Clin Res; 1983; 15 Suppl 37():21-5. PubMed ID: 6433769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes.
    Tan MH; Johns D; Strand J; Halse J; Madsbad S; Eriksson JW; Clausen J; Konkoy CS; Herz M;
    Diabet Med; 2004 Aug; 21(8):859-66. PubMed ID: 15270789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of two glibenclamide preparations, HB 419 and HB 420, in maturity-onset (type 2) diabetic patients.
    Arnala I; Uusitupa M
    Ann Clin Res; 1983; 15 Suppl 37():33-5. PubMed ID: 6433770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
    Ledermann H; Höxter G
    Fortschr Med; 1994 Nov; 112(32):467-70. PubMed ID: 7821886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meal-induced platelet activation in Type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide.
    Yngen M; Ostenson CG; Hjemdahl P; Wallén NH
    Diabet Med; 2006 Feb; 23(2):134-40. PubMed ID: 16433710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with Type 2 diabetes.
    Gallagher A; Home PD
    Diabetes Res Clin Pract; 2005 Mar; 67(3):196-203. PubMed ID: 15713351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.
    Groop L; Wåhlin-Boll E; Groop PH; Tötterman KJ; Melander A; Tolppanen EM; Fyhrqvist F
    Eur J Clin Pharmacol; 1985; 28(6):697-704. PubMed ID: 3933984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the effect and tolerability of two glibenclamide preparations with different release rates].
    Schlich D; Lichtenberger K; Klingmann I; Pabst G; Jaeger H
    Arzneimittelforschung; 1990 Oct; 40(10):1102-5. PubMed ID: 2127178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of antacids on the bioavailability of glibenclamide.
    Zuccaro P; Pacifici R; Pichini S; Avico U; Federzoni G; Pini LA; Sternieri E
    Drugs Exp Clin Res; 1989; 15(4):165-9. PubMed ID: 2505996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of action of combined administration of glibenclamide and insulin in type II diabetics with secondary failure of oral treatment].
    Schmidt FH; Klujko J; Kühnle HF; Reiter J
    Klin Wochenschr; 1986 Oct; 64(20):1021-3. PubMed ID: 3097384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How does glibenclamide lower plasma glucose concentration in patients with type 2 diabetes?
    Jeng CY; Hollenbeck CB; Wu MS; Chen YD; Reaven GM
    Diabet Med; 1989; 6(4):303-8. PubMed ID: 2524334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved diabetic control in insulin-dependent diabetics treated with insulin and glibenclamide.
    Burke BJ; Hartog M; Waterfield MR
    Acta Endocrinol (Copenh); 1984 Sep; 107(1):70-7. PubMed ID: 6435371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glibenclamide steady state plasma levels during concomitant vinpocetine administration in type II diabetic patients.
    Grandt R; Braun W; Schulz HU; Lührmann B; Frercks HJ
    Arzneimittelforschung; 1989 Nov; 39(11):1451-4. PubMed ID: 2515864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glibenclamide pharmacokinetics in acarbose-treated type 2 diabetics.
    Gerard J; Lefebvre PJ; Luyckx AS
    Eur J Clin Pharmacol; 1984; 27(2):233-6. PubMed ID: 6437842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [14C-Glibenclamide concentrations in serum and 14C-glibenclamide urine excretion in diabetic patients with simultaneous determination of blood glucose and insulin (author's transl)].
    Birk W; Schmidt HA; Petrides P
    Arzneimittelforschung; 1978; 28(2):330-7. PubMed ID: 416832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.